This article is more than 5 years old. Information may no longer be current.

Escalon announces FDA approval of portable UBM

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Escalon Medical Corp. announced in a press release that it has received U.S. Food and Drug Administration 510(k) clearance for its Sonomed Escalon VuPad.

The company said in the release that the portable VuPad combines its ultrasound biomicroscopy (UBM) with an ultra-high-resolution screen. The system can capture both still images and video clips and is operated by touch-screen controls.

The VuPad offers A-scan, B-scan and UBM modalities in a “tablet-like package,” the company said. Other features include portability, wireless interconnectivity to electronic medical records and image management systems.

Escalon plans to immediately begin shipping VuPad systems as orders are received, according to the release. It also anticipates CE mark approval and clearance in other countries.

"We are pleased by the initial indications and the long-term opportunity surrounding the VuPad and other new products in our pipeline; however, we may experience sales fluctuations as we update our product offering,” Escalon CEO Richard J. DePiano Jr. said in the release. “In addition, planned increases to research and development expenses as well as increased sales and marketing costs could pressure financial results.”